Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine

被引：0
|
作者：
Yoshinori Ito
Yohei Osaki
Nahomi Tokudome
Tsutomu Sugihara
Shunji Takahashi
Takuji Iwase
Kiyohiko Hatake
机构：
[1] The Cancer Institute of Japanese Foundation for Cancer Research,Department of Medical Oncology
[2] Cancer Institute Hospital,Department of Breast Oncology
[3] Japanese Foundation for Cancer Research,undefined
来源：
Breast Cancer | 2009年 / 16卷
关键词：
S-1; Capecitabine; Taxane; Anthracycline; Metastatic breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：126 / 131
页数：5
相关论文
共 50 条
  • [31] A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer
    Sym, Sun Jin
    Hong, Junshik
    Ahn, Hee Kyung
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Lee, Won-Suk
    Baek, Jeong-Heum
    Park, Yeon Ho
    Shin, Dong Bok
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Utidelone plus capecitabine versus capecitabine for heavily pretreated metastatic breast cancer and CIPN: Analysis of a single centre cohort
    Xu, Junnnan
    Sun, Tao
    CANCER RESEARCH, 2020, 80 (04)
  • [33] Clinical benefit of fulvestrant in heavily pretreated patients with metastatic breast cancer
    Scandurra, Giuseppa
    Carillio, Guido
    Aiello, Rosa Anna
    Chiarenza, Maurizio
    Mazzola, Antonella
    Ali, Marco
    Barone, Gloria
    Greco, Filippo
    Caruso, Michele
    ANNALS OF ONCOLOGY, 2007, 18 : 44 - 44
  • [34] Daily oral etoposide in patients with heavily pretreated metastatic breast cancer
    Pusztai, L
    Walters, RS
    Valero, V
    Theriault, RL
    Hortobagyi, GN
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (05): : 442 - 446
  • [35] Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients
    Kossoff, Ellen B.
    Ngamphaiboon, Nuttapong
    Laudico, Thomas J.
    O'Connor, Tracey L.
    MEDICAL ONCOLOGY, 2011, 28 : S115 - S120
  • [36] Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients
    Ellen B. Kossoff
    Nuttapong Ngamphaiboon
    Thomas J. Laudico
    Tracey L. O’Connor
    Medical Oncology, 2011, 28 : 115 - 120
  • [37] A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer.
    Sym, Sun Jin
    Hong, Junshik
    Jung, Minkyu
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Lee, Won-Suk
    Baek, Jeong-Heum
    Shin, Dong Bok
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Mitomycin c and capecitabine combination (MiXe) in heavily pretreated metastatic breast cancer patients. A dose-finding study
    Maisano, R
    Caristi, N
    Mare, M
    Mafodda, A
    Carboni, R
    Montalto, E
    Iorfida, M
    Nardi, M
    ANTICANCER RESEARCH, 2005, 25 (6C) : 4513 - 4517
  • [39] Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients
    Alfredo Torres
    Jeremy L. Ramdial
    Luis E. Aguirre
    Reshma Mahtani
    Charles L. Vogel
    Breast Cancer Research and Treatment, 2019, 176 : 253 - 260
  • [40] Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients
    Torres, Alfredo
    Ramdial, Jeremy L.
    Aguirre, Luis E.
    Mahtani, Reshma
    Vogel, Charles L.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 253 - 260
12345